UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - pluripotent+stem+cell+(psc)
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Gene Modifications to Enhance the Function of PSC-Derived T Cells and NK Cells (UCLA Case No. 2023-129)
UCLA researchers in the Department of Medicine have generated novel pluripotent stem cell derived T cells that exhibit improved survival, expansion, and anti-tumor efficacy for use in cell therapy treatments. BACKGROUND: The Food and Drug Administration has approved several chimeric antigen receptor-T (CAR-T) cell therapies since 2017 to combat lymphoma...
Published: 4/22/2025
|
Inventor(s):
Christopher Seet
Keywords(s):
CAR-T cell therapy
,
Immunotherapy
,
pluripotent stem cell (PSC)
,
T-cell engineering
Category(s):
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Gene Therapy And Editing
Viral Vector-Based Gene Therapy for OPA1 Gene Mutation-Induced Dominant Optic Atrophy (UCLA Case No. 2025-004)
UCLA researchers in the Department of Ophthalmology have developed a viral vector-based gene therapy to restore OPA1 protein levels in patients with OPA1-mutated dominant optic atrophy. The optimized vectors will be delivered intravitreally to patients’ eyes, providing a minimally invasive, effective treatment with reduced side effects. BACKGROUND:...
Published: 3/6/2025
|
Inventor(s):
Xianjie Yang
Keywords(s):
Adeno-associated viruses (AAV)
,
disease model
,
dominant optic atrophy
,
Gene Therapy
,
intravitreal delivery
,
Lentivirus Viral Vector
,
mitochondria
,
mutation
,
Neuron
,
OPA1
,
Ophthalmology
,
pluripotent stem cell (PSC)
,
retinal ganglion cell
Category(s):
Therapeutics > CNS and Neurology
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Ophthalmology